Actively Recruiting

Age: 18Years +
All Genders
NCT07060547

Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease

Led by HepQuant, LLC · Updated on 2025-07-11

40

Participants Needed

1

Research Sites

350 weeks

Total Duration

On this page

Sponsors

H

HepQuant, LLC

Lead Sponsor

L

Leland Stanford Junior University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a study to measure liver recovery in patients with recent alcohol-associated liver injury by assessing liver function and physiology using HepQuant DuO. The HepQuant DuO Test is a blood-based test that involves a drink of a natural compound, cholate, and 2 blood samples at 20 and 60 minutes. The study team is collecting clinical and laboratory data to better monitor and treat patients who have been affected by alcohol-associated liver disease. The study has 4 visits at an outpatient clinic at 1, 3, 6, and 12 months. At each of these visits, participants will undergo a HepQuant DuO test and other standard tests. In addition, the study team will ask about a participant's alcohol use, symptoms, and quality of life.

CONDITIONS

Official Title

Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult with a clinical diagnosis of liver disease due to alcohol who have acute hepatic decompensation
  • Adult with a combined clinical diagnosis of alcohol-related liver disease (ALD) and nonalcoholic steatohepatitis (NASH)
Not Eligible

You will not qualify if you...

  • Clinical diagnosis of liver disease with an etiology other than alcohol liver disease unless combined ALD and NASH
  • Patients with solid organ malignancy
  • Patients with other liver disease including autoimmune, drug-related injury, hemochromatosis, or Wilson's disease
  • Pregnancy
  • Under the age of 18

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Stanford University Dept. of Medicine -Gastroenterology & Hepatology

Redwood City, California, United States, 94063

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here